Invivyd (IVVD) Invested Capital (2020 - 2025)
Invivyd posted quarterly Invested Capital of $241.5 million for Q4 2025, up 257.63% year-on-year from $67.5 million in Q4 2024, and up 159.53% on a QoQ basis from $93.1 million in Q3 2025.
Invivyd (IVVD) has 6 years of Invested Capital data on file, last reported at $241.5 million in Q4 2025.
- For the quarter ending Q4 2025, Invested Capital rose 257.63% year-over-year to $241.5 million; the trailing twelve-month figure through Dec 2025 stood at $241.5 million (up 257.63% YoY), and the FY2025 full-year result was $241.5 million, up 257.63% from the prior year.
- Invested Capital for Q4 2025 stood at $241.5 million, up from $93.1 million in the prior quarter.
- Across five years, Invested Capital topped out at $633.2 million in Q3 2021 and bottomed at -$144.6 million in Q2 2021.
- The 5-year median for Invested Capital is $210.0 million (2024), against an average of $224.2 million.
- The widest annual swing landed in 2021, when Invested Capital surged 955.21%; it then slumped 69.66% in 2025.
- A 5-year view of Invested Capital shows it stood at $558.0 million in 2021, then sank by 36.21% to $356.0 million in 2022, then slumped by 50.15% to $177.5 million in 2023, then tumbled by 61.94% to $67.5 million in 2024, then surged by 257.63% to $241.5 million in 2025.
- The last three Invested Capital figures came in at $241.5 million (Q4 2025), $93.1 million (Q3 2025), and $42.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Invivyd | 208.38 Mn | -18.31 Mn | - | 241.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 241.54 Mn |
| Sep 30, 2025 | 93.07 Mn |
| Jun 30, 2025 | 42.79 Mn |
| Mar 31, 2025 | 54.15 Mn |
| Dec 31, 2024 | 67.54 Mn |
| Sep 30, 2024 | 83.16 Mn |
| Jun 30, 2024 | 140.64 Mn |
| Mar 31, 2024 | 178.50 Mn |
| Dec 31, 2023 | 177.47 Mn |
| Sep 30, 2023 | 246.50 Mn |
| Jun 30, 2023 | 281.56 Mn |
| Mar 31, 2023 | 326.75 Mn |
| Dec 31, 2022 | 355.97 Mn |
| Sep 30, 2022 | 377.44 Mn |
| Jun 30, 2022 | 414.84 Mn |
| Mar 31, 2022 | 459.39 Mn |
| Dec 31, 2021 | 558.02 Mn |
| Sep 30, 2021 | 633.21 Mn |
| Jun 30, 2021 | -144.62 Mn |
| Mar 31, 2021 | -103.36 Mn |
| Dec 31, 2020 | -65.25 Mn |